Pál Czobor

Statistics

Publications

141

Citations

9.8K

H-Index

Active since

1990

Affiliations

Nathan Kline Institute for Psychiatric Research(Current)

Semmelweis University

New York University

Eötvös Loránd University

Manhattan Psychiatric Center

Pál Czobor is an author at Nathan Kline Institute for Psychiatric Research specializing in psychiatry, psychopharmacology, and schizophrenia spectrum disorders.

ORCID

Publications per year

1990–2024

141

Publications

141

Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder

Robert M. Bilder, Robert Goldman, Jan Volavka et al. · American Journal of Psychiatry · 2002 · 538 citations

Medicine, Pharmacology, Psychiatry +17

Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics

Jean-Pierre Lindenmayer, Pál Czobor, Jan Volavka et al. · American Journal of Psychiatry · 2003 · 466 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder

Jan Volavka, Pál Czobor, Brian Sheitman et al. · American Journal of Psychiatry · 2002 · 409 citations

Medicine, Pharmacotherapy, Psychiatry +17

Atypical Antipsychotic Agents in the Treatment of Violent Patients With Schizophrenia and Schizoaffective Disorder

Menahem Krakowski, Pál Czobor, Leslie Citrome et al. · Archives of General Psychiatry · 2006 · 354 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial

György Németh, I. Laszlovszky, Pál Czobor et al. · The Lancet · 2017 · 352 citations

Pharmacy, Pharmacotherapy, Psychiatry +14

1–5 of 141